Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2011

Open Access 01.12.2011 | Case report

Littoral cell angioma of the spleen in a patient with previous pulmonary sarcoidosis: a TNF-α related pathogenesis?

verfasst von: Stefanie Cordesmeyer, Manfred Pützler, Ulf Titze, Harald Paulus, Matthias W Hoffmann

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2011

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Littoral cell angioma (LCA) is a rare vascular tumor of the spleen. Generally thought to be benign, additional cases of LCA with malignant features have been described. Thus, its malignant potential seems to vary and must be considered uncertain. The etiology remains unclear, but an immune dysregulation for the apparent association with malignancies of visceral organs or immune-mediated diseases has been proposed.

Case Presentation

We report a case of LCA in a 43-year old male patient who presented with a loss of appetite and intermittent upper abdominal pain. Computed tomography showed multiple hypoattenuating splenic lesions which were hyperechogenic on abdominal ultrasound. Lymphoma was presumed and splenectomy was performed. Pathological evaluation revealed LCA.

Conclusions

LCA is a rare, primary vascular neoplasm of the spleen that might etiologically be associated with immune dysregulation. In addition, it shows a striking association with synchronous or prior malignancies. With about one-third of the reported cases to date being co-existent with malignancies of visceral organs or immune-mediated diseases, this advocates for close follow-ups in all patients diagnosed with LCA. To our knowledge, this report is the first one of LCA associated with previous pulmonary sarcoidosis and hypothesizes a TNF-α related pathogenesis of this splenic tumor.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-9-106) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SC reviewed relevant literature and wrote the initial draft. MP reviewed the draft and contributed the CT scans. UT contributed the histological images. HP provided clinical expertise and reviewed the manuscript. MWH performed the surgery and reviewed the manuscript. All authors read and approved the final manuscript.

Background

Vascular tumors are the most common primary neoplasms of the spleen. Among these, LCA is a very rare tumor which arises from the littoral cells lining the sinuses of the splenic red pulp. The tumor displays a unique immunohistochemical phenotype of dual endothelial and histiocytic differentiation but is difficult to differentiate from other benign and malignant splenic lesions preoperatively. Thus, diagnosis is usually established after elective splenectomy. Currently, both etiology as well as biological behavior remain uncertain. Increasing numbers of LCA in association with autoimmune disorders or visceral organ tumors have been reported which hypothesizes an immunological association of this entity.

Case presentation

A 43-year old male presented with non-specific clinical symptoms such as loss of appetite and intermittent upper abdominal pain which improved slightly with antacid medication. His medical history was unremarkable except for pulmonal sarcoidosis in his twenties which had been treated with corticosteroid medication. Both physical examination and laboratory tests were without pathological findings. An ulcerous lesion in the duodenum was detected gastroscopically and computed tomography was performed to exclude an external compressing tumor. CT scans (Figure 1) did not detect any tumor but revealed mild splenomegaly with multiple hypoattenuating nodules with a maximum diameter of 2.5 cm which were contrast-enhancing in the late portal venous phase.
Abdominal ultrasound revealed multiple hyperechogenic splenic lesions without evidence of metastatic disease or infectious origin and hemangioma was assumed. Despite the absence of adenopathy, lymphoma was finally considered the most likely diagnosis, given the quantity of the nodules as well as their distribution within the spleen and splenectomy was advocated. After appropriate preoperative vaccination for Streptococcus pneumoniae, Haemophilus influenca B and Neisseria meningitidis, laparoscopic splenectomy was performed. The cut surface of the 12 × 8 × 4 cm specimen (Figure 2) showed multiple nodular lesions with spongy appearance, varying from 0.5 to 2 cm in greatest dimension.
Microscopically, these lesions were composed of cavernous sinuses which were lined by a single layer of tall cells (Figure 3) lacking typical endothelial features. The lacunae were filled with edematous fluid and blood (Figure 4). Immunohistochemical staining (Figure 5) was positive for both endothelial (CD 31) and histiocytic (CD 68) markers. No cytologic atypia and mitotic figures were found.
The combination of morphological and immunohistochemical analysis presenting this hybrid endothelial-histiocytic phenotype established the diagnosis of LCA. The postoperative course was uneventful and the patient was discharged on day five. He will be followed-up closely for the occurrence t of visceral neoplasms.

Discussion

Littoral cell angioma (LCA) is a rare vascular tumor that occurs exclusively in splenic tissue and was first described by Falk et al in 1991 [1]. It originates from the specialized endothelial cells lining the sinus channels of the splenic red pulp, called "littoral cells". LCA show neither gender nor age predilection. It might be discovered incidentally in completely asymptomatic patients or in those presenting with non-specific clinical symptoms like in our case. About 50% of all patients show splenomegaly or signs of hypersplenism like anemia or thrombocytopenia [1]. On ultrasound, the findings vary widely from heterogeneous echotexture without specific nodules [2] to hyperechogenic [3], hypoechogenic [4] or isoechogenic [5] appearing lesions [68]. Computed tomography typically shows multiple hypoattenuating nodules [9]. These findings are non-specific and several differential diagnosis have to be considered. These include benign neoplasms like hamartoma or hemangioma but also metastatic diseases or disseminated infections [2]. Since our patient did not present with adenopathy or disease in other organs, metastatic disease was considered an unlikely diagnosis. Considering disseminated infections, we had to exclude fungal disease, septic emboli and granulomatous diseases such as sarcoidosis and tuberculosis. Associated adenopathic, pulmonary and mediastinal diseases suspecting sarcoidosis or tuberculosis were not detected. Mycobacterium avium-intracellulare complex, Pneumocystic carinii and disseminated Kaposi sarcoma may also cause splenic masses but are typically seen in immunocompromised individuals. After elaborating for these differentials, a definite diagnosis is often still difficult to obtain and splenectomy is subsequently performed for further evaluation. Gross pathology typically shows multiple focal blood-filled nodules and microscopic examination reveals anastomosing vascular channels lined with tall endothelial cells and papillary fronds [1, 7, 9].
Since the littoral cells have features intermediate between those of endothelial cells and macrophages, they show a hybrid endothelial-histiocytic phenotype on immunohistochemical staining. Expression of endothelial marker factor VIII-related antigen and also of histiocytic markers such as CD68 and lysozyme is thought to be characteristic for LCA [1, 6, 7] and establishes the final diagnosis.
Generally thought to be benign, there are additional reports of LCA with malignant features which were divided into a low-grade variant (littoral cell hemangioendothelioma [10]) and the tumor's malignant counterpart, littoral cell angiosarcoma [11]. Therefore, its biological behavior seems to vary and must be considered uncertain [9].
The etiology of this neoplasm also remains unclear, but for its apparent association with visceral organ tumors and immune-mediated diseases in one-third of the reported cases to date [1216], an etiological association with immune dysregulation has been proposed [1, 17, 18]. To support this contention, there are more reports of LCA in patients with long-term immunosupressive therapy, i.e. after renal transplantation [18] or for systemic lupus erythematosus [19]. Reviewing literature for similarities of immune-mediated diseases and LCA we found two cases of LCA in patients with Gaucher's disease [20, 21], a lipid storage disorder characterized by accumulation of cerebroside in the cytoplasm of macrophages due to deficiency of an enzyme, glucocerebrosidase [20, 21]. Both LCA and Gaucher's disease involve lysozymes. Since the likelihood of chance occurrence of two rare disorders in one patient is low, Gupka et al suggested a possible pathophysiologic association [20].
Since our patient had a history of pulmonal sarcoidosis, we concentrated on possible immunological links between these two entities.
In sarcoidosis, a multisystemic granulomatous disorder of unknown origin, the inflammatory response is characterized by the increased production of several pro-inflammatory cytokines which mainly belong to the tumor necrosis factor family. Tumor necrosis factor-alpha (TNF-α) is considered the pivotal factor in the formation of granulomas by mediating inflammation and cellular immune response among the cytokines involved [22]. TNF-α is released by macrophages and binds to two types of receptors, the 55 kDa (TNF receptor I: TNF RI) and the 75 kDa receptor (TNF RII) [23]. Elevated serum levels of these receptors have been demonstrated in a variety of diseases, e.g. rheumatic diseases, malignancies and Crohn's disease, and are thought to reflect the disease activity. Since LCA is a neoplasm arising from the lining cells, the spleen's macrophages, this could also be an area of increased production of TNF-α, eventually contributing to the pathogenesis of LCA, since inflammatory cells including TNF-α are known to have powerful effects on tumor development, producing an attractive environment for tumor growth by facilitating genomic instability and promoting angiogenesis. The inflammatory cells as well as the chemokines and cytokines they produce finally influence the whole tumor organ, regulating the growth, migration and differentiation of all cell types in the tumor microenvironment, including neoplastic cells, fibroblasts and endothelial cells [24]. Thus, a TNF-α related pathogenesis of LCA could also provide an explanation for both the occurrence of synchronous or metachronous visceral organ tumors as well as the affection for immune-mediated diseases.

Conclusions

LCA is a rare, primary vascular neoplasm of the spleen. Currently, both etiology and biological behavior remain unclear, but an underlying immune dysregulation has been proposed for LCA's association with malignancies of visceral organs or immune-mediated disorders in about one-third of the reported cases. Our case presentation supports the assumption of an association of LCA and an altered immune status, hypothesizing a TNF-α-related pathogenesis of this splenic tumor. Close follow-ups of patients diagnosed with LCA for subsequent development of additional tumors is mandatory.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SC reviewed relevant literature and wrote the initial draft. MP reviewed the draft and contributed the CT scans. UT contributed the histological images. HP provided clinical expertise and reviewed the manuscript. MWH performed the surgery and reviewed the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Falk S, Stutte HJ, Frizzera G: Littoral cell angioma: a novel splenic vascular lesion demonstrating histiocytic differentiation. Am J Surg Pathol. 1991, 15: 1023-1033.CrossRefPubMed Falk S, Stutte HJ, Frizzera G: Littoral cell angioma: a novel splenic vascular lesion demonstrating histiocytic differentiation. Am J Surg Pathol. 1991, 15: 1023-1033.CrossRefPubMed
2.
Zurück zum Zitat Kinoshita LL, Yee J, Nash SR: Littoral cell angioma of the spleen: imaging features. AJR. 2000, 174: 467-469.CrossRefPubMed Kinoshita LL, Yee J, Nash SR: Littoral cell angioma of the spleen: imaging features. AJR. 2000, 174: 467-469.CrossRefPubMed
3.
Zurück zum Zitat Espanol I, Lerma E, Fumanal V: Littoral cell angioma with severe thrombocytopenia. Ann Hematol. 2000, 79: 46-CrossRefPubMed Espanol I, Lerma E, Fumanal V: Littoral cell angioma with severe thrombocytopenia. Ann Hematol. 2000, 79: 46-CrossRefPubMed
4.
Zurück zum Zitat Ziske C, Meyebehm M, Sauerbruch LGH: Littoral cell angioma as a rare cause of splenomegaly. Ann Hematol. 2001, 80: 45-CrossRefPubMed Ziske C, Meyebehm M, Sauerbruch LGH: Littoral cell angioma as a rare cause of splenomegaly. Ann Hematol. 2001, 80: 45-CrossRefPubMed
5.
Zurück zum Zitat Oliver-Goldaracena JM, Blanco A, Miralles M, Martin-Gonzalez MA: Littoral cell angioma of the spleen: US and MR imaging findings. Abdom Imaging. 1998, 23: 636-639.CrossRefPubMed Oliver-Goldaracena JM, Blanco A, Miralles M, Martin-Gonzalez MA: Littoral cell angioma of the spleen: US and MR imaging findings. Abdom Imaging. 1998, 23: 636-639.CrossRefPubMed
6.
Zurück zum Zitat Goldfield M, Cohen I, Loberant N: Littoral cell angioma of the spleen: appearance on sonography and CT. J Clini Ultrasound. 2002, 30: 510-513.CrossRef Goldfield M, Cohen I, Loberant N: Littoral cell angioma of the spleen: appearance on sonography and CT. J Clini Ultrasound. 2002, 30: 510-513.CrossRef
7.
Zurück zum Zitat Levy AD, Abbott RM, Abbondanzo SL: Littoral cell angioma of the spleen: CT features with clinicopathologic comparison. Radiology. 2004, 230: 485-490.CrossRefPubMed Levy AD, Abbott RM, Abbondanzo SL: Littoral cell angioma of the spleen: CT features with clinicopathologic comparison. Radiology. 2004, 230: 485-490.CrossRefPubMed
8.
Zurück zum Zitat Bhatt S, Huang J, Dogra V: Littoral cell angioma of the spleen. AJR American J Roentgenol. 2007, 188: 1365-1366.CrossRef Bhatt S, Huang J, Dogra V: Littoral cell angioma of the spleen. AJR American J Roentgenol. 2007, 188: 1365-1366.CrossRef
9.
Zurück zum Zitat Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM: From the archives of the AFIP: primary vascular neoplasms of the spleen-radiologic-pathological correlation. RadioGraphics. 2004, 24: 1137-1163.CrossRefPubMed Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM: From the archives of the AFIP: primary vascular neoplasms of the spleen-radiologic-pathological correlation. RadioGraphics. 2004, 24: 1137-1163.CrossRefPubMed
10.
Zurück zum Zitat Ben-Izhak O, Bejar J, Ben-Eliezer S, Vlodavsky E: Splenic littoral cell haemangioendothelioma: a new low-grade variant of malignant littoral cell tumour. Histopathology. 2001, 39: 469-475.CrossRefPubMed Ben-Izhak O, Bejar J, Ben-Eliezer S, Vlodavsky E: Splenic littoral cell haemangioendothelioma: a new low-grade variant of malignant littoral cell tumour. Histopathology. 2001, 39: 469-475.CrossRefPubMed
11.
Zurück zum Zitat Rosso R, Paulli M, Gianelli U, Boveri E, Stella G, Magrini U: Littoral cell angiosarcoma of the spleen. Case report with immunohistochemical and ultrastructural analysis. Am J Surg Pathol. 1995, 19: 1203-1208.CrossRefPubMed Rosso R, Paulli M, Gianelli U, Boveri E, Stella G, Magrini U: Littoral cell angiosarcoma of the spleen. Case report with immunohistochemical and ultrastructural analysis. Am J Surg Pathol. 1995, 19: 1203-1208.CrossRefPubMed
12.
Zurück zum Zitat Bisceglia M, Sickel JZ, Giangaspero F, Gomes V, Amini M, Michal M: Littoral cell angioma of the spleen: an additional report of four cases with emphasis on the association with visceral organ cancers. Tumori. 1998, 84: 595-599.PubMed Bisceglia M, Sickel JZ, Giangaspero F, Gomes V, Amini M, Michal M: Littoral cell angioma of the spleen: an additional report of four cases with emphasis on the association with visceral organ cancers. Tumori. 1998, 84: 595-599.PubMed
13.
Zurück zum Zitat Collins GL, Morgan MB, Taylor FM: Littoral cell angiomatosis with poorly differentiated adenocarcinoma of the lung. Ann Diagn Pathol. 2003, 7: 54-59.CrossRefPubMed Collins GL, Morgan MB, Taylor FM: Littoral cell angiomatosis with poorly differentiated adenocarcinoma of the lung. Ann Diagn Pathol. 2003, 7: 54-59.CrossRefPubMed
14.
Zurück zum Zitat Lin CH, Yu JC, Shih ML, Peng YJ, Hsieh CB: Littoral cell angioma of the spleen in a patient with hepatocellular carcinoma. J Formos Med Assoc. 2005, 104: 282-285.PubMed Lin CH, Yu JC, Shih ML, Peng YJ, Hsieh CB: Littoral cell angioma of the spleen in a patient with hepatocellular carcinoma. J Formos Med Assoc. 2005, 104: 282-285.PubMed
15.
Zurück zum Zitat Ercin C, Gurbuz Y, Hacihanefioglu A, Turgut Karakaya A: Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome. Hematology. 2005, 10: 141-144.CrossRefPubMed Ercin C, Gurbuz Y, Hacihanefioglu A, Turgut Karakaya A: Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome. Hematology. 2005, 10: 141-144.CrossRefPubMed
16.
Zurück zum Zitat Hansen T, Habekost M, Flieger D, Kirkpatrick CJ: Littoral cell angioma of the spleen: Association with colon and hepatocellular carcinoma. Pathologe. 2010, 31 (4): 290-292.CrossRefPubMed Hansen T, Habekost M, Flieger D, Kirkpatrick CJ: Littoral cell angioma of the spleen: Association with colon and hepatocellular carcinoma. Pathologe. 2010, 31 (4): 290-292.CrossRefPubMed
17.
Zurück zum Zitat Tholouli E, Roulson JA, Byers R: Littoral cell angioma of the spleen in a patient with severe aplastic anemia. Haematologica. 2003, 88: 11, ECR33- Tholouli E, Roulson JA, Byers R: Littoral cell angioma of the spleen in a patient with severe aplastic anemia. Haematologica. 2003, 88: 11, ECR33-
18.
Zurück zum Zitat Tan YM, Chuah KL, Wong WK: Littoral cell angioma of the spleen. Ann Acad Med Singapore. 2004, 33: 524-526.PubMed Tan YM, Chuah KL, Wong WK: Littoral cell angioma of the spleen. Ann Acad Med Singapore. 2004, 33: 524-526.PubMed
19.
Zurück zum Zitat Gupka MK, Levin M, Aguilera NS, Pastores GM: Littoral cell angioma of the spleen in a patient with Gaucher disease. Am J Hematol. 2001, 68: 61-62.CrossRef Gupka MK, Levin M, Aguilera NS, Pastores GM: Littoral cell angioma of the spleen in a patient with Gaucher disease. Am J Hematol. 2001, 68: 61-62.CrossRef
20.
Zurück zum Zitat Forest F, Duband S, Clemenson A, Peoc'h M: Traumatic subcapsular splenic hematoma revealing littoral cell angioma and Gaucher's disease. Ann Hematol. 2010, 89 (10): 1061-1062.CrossRefPubMed Forest F, Duband S, Clemenson A, Peoc'h M: Traumatic subcapsular splenic hematoma revealing littoral cell angioma and Gaucher's disease. Ann Hematol. 2010, 89 (10): 1061-1062.CrossRefPubMed
21.
Zurück zum Zitat Mac New HG, Fowler CL: Partial splenectomy for littoral cell angioma. Journal of Pediatric Surgery. 2008, 43: 2288-2290.CrossRefPubMed Mac New HG, Fowler CL: Partial splenectomy for littoral cell angioma. Journal of Pediatric Surgery. 2008, 43: 2288-2290.CrossRefPubMed
22.
Zurück zum Zitat Ziegenhagen MW, Müller-Quernheim J: The cytokine network in sarcoidosis and its clinical relevance. Journal of Internal Medicine. 2003, 253: 18-30.CrossRefPubMed Ziegenhagen MW, Müller-Quernheim J: The cytokine network in sarcoidosis and its clinical relevance. Journal of Internal Medicine. 2003, 253: 18-30.CrossRefPubMed
23.
Zurück zum Zitat Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA. 1990, 87: 3127-3131.PubMedCentralCrossRefPubMed Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA. 1990, 87: 3127-3131.PubMedCentralCrossRefPubMed
Metadaten
Titel
Littoral cell angioma of the spleen in a patient with previous pulmonary sarcoidosis: a TNF-α related pathogenesis?
verfasst von
Stefanie Cordesmeyer
Manfred Pützler
Ulf Titze
Harald Paulus
Matthias W Hoffmann
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2011
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-9-106

Weitere Artikel der Ausgabe 1/2011

World Journal of Surgical Oncology 1/2011 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.